abstract |
The invention belongs to the field of biomedicine, and relates to the application of the combined use of a Caspase activator and an oncolytic virus in the preparation of antitumor drugs. The present invention finds for the first time that the Caspase activator can increase the anti-tumor effect of the oncolytic virus, and the combination of the two has a strong synergistic effect and provides an effective treatment plan for tumor treatment with low drug sensitivity. |